Xolair subcutaneous injection 150mg (YJ code: 2290400D1033, standard: 1 bottle of 150mg) is a Novartis Pharma medication containing Omalizumab (genetical recombination). It is used for moderate to severe persistent asthma in patients aged 6 years and older, chronic spontaneous urticaria, and chronic rhinosinusitis with nasal polyps.
Xolair subcutaneous injection 150mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).